CVS HealthPrefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
CVS Health (CVS) reported revenue of $100.43B in Q1 2026, with Pharmacy Revenue its largest revenue segment at 57%.
CVS HealthIntegrated payer, PBM, and retail pharmacy (Aetna, Caremark, about 9,000 stores). Caremark holds the strongest single lever over US GLP-1 access: it made Wegovy the preferred weight-management drug from July 2025 and removed Zepbound, then added Zepbound back at the same tier effective October 1, 2026.
CVS Health (CVS) is a Medical - Healthcare Plans company. Integrated payer, PBM, and retail pharmacy (Aetna, Caremark, about 9,000 stores). Caremark holds the strongest single lever over US GLP-1 access: it made Wegovy the preferred weight-management drug from July 2025 and removed Zepbound, then added Zepbound back at the same tier effective October 1, 2026. It was founded in 1963, is headquartered in Woonsocket, RI and employs about 300,000 people.
As of 2026-Q1, CVS Health's revenue breaks down across Pharmacy Revenue (57%), Premiums (34%), Front Store Revenue (5%), Product and Service, Other (4%). See the revenue-by-segment chart for the full mix.
Track CVS Health's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated September 28, 2026.
Sterling groups CVS Health in the GLP-1 industry, alongside Hims & Hers Health (HIMS), McKesson (MCK), Cencora (COR) and Cardinal Health (CAH). Sterling also tracks it in the Healthcare industry.
If you are researching CVS Health, also look at Hims & Hers Health (HIMS), McKesson (MCK) and Cencora (COR). You can compare all of them side by side or browse the full GLP-1 industry on Sterling.
Q2 2016-Q1 2026
Q2 2016-Q1 2026